178 related articles for article (PubMed ID: 38481282)
1. TP63-TRIM29 axis regulates enhancer methylation and chromosomal instability in prostate cancer.
Sultanov R; Mulyukina A; Zubkova O; Fedoseeva A; Bogomazova A; Klimina K; Larin A; Zatsepin T; Prikazchikova T; Lukina M; Bogomiakova M; Sharova E; Generozov E; Lagarkova M; Arapidi G
Epigenetics Chromatin; 2024 Mar; 17(1):6. PubMed ID: 38481282
[TBL] [Abstract][Full Text] [Related]
2. TRIM29 as a novel prostate basal cell marker for diagnosis of prostate cancer.
Kanno Y; Watanabe M; Kimura T; Nonomura K; Tanaka S; Hatakeyama S
Acta Histochem; 2014 Jun; 116(5):708-12. PubMed ID: 24485335
[TBL] [Abstract][Full Text] [Related]
3. TRIM29 regulates the p63-mediated pathway in cervical cancer cells.
Masuda Y; Takahashi H; Hatakeyama S
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2296-305. PubMed ID: 26071105
[TBL] [Abstract][Full Text] [Related]
4. Immune infiltration phenotypes of prostate adenocarcinoma and their clinical implications.
Ma Z; Cheng X; Yue T; Shangguan X; Xin Z; Zhang W; Pan J; Wang Q; Xue W
Cancer Med; 2021 Aug; 10(15):5358-5374. PubMed ID: 34128342
[TBL] [Abstract][Full Text] [Related]
5. ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer.
Kunderfranco P; Mello-Grand M; Cangemi R; Pellini S; Mensah A; Albertini V; Malek A; Chiorino G; Catapano CV; Carbone GM
PLoS One; 2010 May; 5(5):e10547. PubMed ID: 20479932
[TBL] [Abstract][Full Text] [Related]
6. Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2.
Cheng J; Zhou J; Fu S; Fu J; Zhou B; Chen H; Fu J; Wei C
J Cell Mol Med; 2021 Apr; 25(8):4157-4165. PubMed ID: 33609069
[TBL] [Abstract][Full Text] [Related]
7. ATDC mediates a TP63-regulated basal cancer invasive program.
Palmbos PL; Wang Y; Bankhead Iii A; Kelleher AJ; Wang L; Yang H; Ahmet ML; Gumkowski ER; Welling SD; Magnuson B; Leflein J; Lorenzatti Hiles G; Abel EV; Dziubinski ML; Urs S; Day ML; Ljungman ME; Simeone DM
Oncogene; 2019 May; 38(18):3340-3354. PubMed ID: 30643195
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive mutational analysis and mRNA isoform quantification of TP63 in normal and neoplastic human prostate cells.
Parsons JK; Saria EA; Nakayama M; Vessella RL; Sawyers CL; Isaacs WB; Faith DA; Bova GS; Samathanam CA; Mitchell R; De Marzo AM
Prostate; 2009 Apr; 69(5):559-69. PubMed ID: 19142959
[TBL] [Abstract][Full Text] [Related]
9. TRIM29 acts as a potential senescence suppressor with epigenetic activation in nasopharyngeal carcinoma.
Yue C; Qian Y; Wang C; Chen J; Wang J; Wang Z; Wan X; Cao S; Zhu J; Tao Q; Yan M; Liu Q
Cancer Sci; 2023 Aug; 114(8):3176-3189. PubMed ID: 37248790
[TBL] [Abstract][Full Text] [Related]
10. TRIM29 suppresses TWIST1 and invasive breast cancer behavior.
Ai L; Kim WJ; Alpay M; Tang M; Pardo CE; Hatakeyama S; May WS; Kladde MP; Heldermon CD; Siegel EM; Brown KD
Cancer Res; 2014 Sep; 74(17):4875-87. PubMed ID: 24950909
[TBL] [Abstract][Full Text] [Related]
11. TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin.
Masuda Y; Takahashi H; Sato S; Tomomori-Sato C; Saraf A; Washburn MP; Florens L; Conaway RC; Conaway JW; Hatakeyama S
Nat Commun; 2015 Jun; 6():7299. PubMed ID: 26095369
[TBL] [Abstract][Full Text] [Related]
12. Micro-RNA-204 Participates in TMPRSS2/ERG Regulation and Androgen Receptor Reprogramming in Prostate Cancer.
Todorova K; Metodiev MV; Metodieva G; Mincheff M; Fernández N; Hayrabedyan S
Horm Cancer; 2017 Feb; 8(1):28-48. PubMed ID: 28050800
[TBL] [Abstract][Full Text] [Related]
13. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of an imprinted gene network in prostate cancer.
Ribarska T; Goering W; Droop J; Bastian KM; Ingenwerth M; Schulz WA
Epigenetics; 2014 May; 9(5):704-17. PubMed ID: 24513574
[TBL] [Abstract][Full Text] [Related]
15. Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma.
Zhang D; Zhang M; Zhang Q; Zhao Z; Nie Y
Med Sci Monit; 2020 Jul; 26():e924543. PubMed ID: 32735556
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis.
Simmonds P; Loomis E; Curry E
Genome Med; 2017 Jun; 9(1):54. PubMed ID: 28592290
[TBL] [Abstract][Full Text] [Related]
17. The Breast Cancer Tumor Suppressor TRIM29 Is Expressed via ATM-dependent Signaling in Response to Hypoxia.
Dükel M; Streitfeld WS; Tang TC; Backman LR; Ai L; May WS; Brown KD
J Biol Chem; 2016 Oct; 291(41):21541-21552. PubMed ID: 27535224
[TBL] [Abstract][Full Text] [Related]
18. Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma.
Yanagi T; Watanabe M; Hata H; Kitamura S; Imafuku K; Yanagi H; Homma A; Wang L; Takahashi H; Shimizu H; Hatakeyama S
Cancer Res; 2018 Dec; 78(24):6795-6806. PubMed ID: 30389700
[TBL] [Abstract][Full Text] [Related]
19. Zinc finger C3H1 domain-containing protein (ZFC3H1) evaluates the prognosis and treatment of prostate adenocarcinoma (PRAD): A study based on TCGA data.
Huang H; Xu H; Li P; Ye X; Chen W; Chen W; Huang X
Bioengineered; 2021 Dec; 12(1):5504-5515. PubMed ID: 34514952
[TBL] [Abstract][Full Text] [Related]
20. Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis.
Berchuck JE; Baca SC; McClure HM; Korthauer K; Tsai HK; Nuzzo PV; Kelleher KM; He M; Steinharter JA; Zacharia S; Spisak S; Seo JH; Conteduca V; Elemento O; Auh J; Sigouros M; Corey E; Hirsch MS; Taplin ME; Choueiri TK; Pomerantz MM; Beltran H; Freedman ML
Clin Cancer Res; 2022 Mar; 28(5):928-938. PubMed ID: 34907080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
